Wikidata

(Q64188534)

English

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

clinical trial

In more languages

Statements

title
PHASE 3B/4 RANDOMIZED SAFETY ENDPOINT STUDY OF 2 DOSES OF TOFACITINIB IN COMPARISON TO A TUMOR NECROSIS FACTOR (TNF) INHIBITOR IN SUBJECTS WITH RHEUMATOID ARTHRITIS (English)
0 references
medical condition
arthritis
0 references
necrosis
0 references
country
Argentina
0 references
Australia
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Chile
0 references
Colombia
0 references
Finland
0 references
Israel
0 references
Jordan
0 references
Lebanon
0 references
Malaysia
0 references
Mexico
0 references
Netherlands
0 references
New Zealand
0 references
Peru
0 references
Poland
0 references
Slovakia
0 references
South Africa
0 references
Spain
0 references
Taiwan
0 references
Thailand
0 references
Turkey
0 references
United Kingdom
0 references
start time
14 March 2014
0 references
end time
3 March 2020
0 references
number of participants
4,400
0 references
minimum age
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64188534&oldid=1857613344"